Coronary Flow Reserve in Patients With Prior Spontaneous Coronary Artery Dissection and Recurrent Angina

Tara Sedlak1, Andrew Starovoytov1, Karin Humphries2

  • 1Division of Cardiology Vancouver General Hospital Vancouver British Columbia Canada.

Insights

Chronic chest pain after spontaneous coronary artery dissection (SCAD) is often linked to coronary microvascular dysfunction. Invasive testing revealed over 70% of patients had this dysfunction, suggesting underlying vasculopathies like fibromuscular dysplasia contribute to persistent symptoms.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Diagnostic Medicine

Background:

  • Spontaneous coronary artery dissection (SCAD) frequently leads to chronic chest pain post-healing.
  • The role of coronary microvascular dysfunction (CMD) in persistent post-SCAD pain is not fully understood.
  • Investigating CMD is crucial for managing long-term symptoms in SCAD patients.

Purpose of the Study:

  • To assess the contribution of coronary microvascular dysfunction to chronic chest pain in SCAD survivors.
  • To evaluate coronary reactivity using invasive testing in patients with post-SCAD chest pain.

Main Methods:

  • Coronary reactivity testing (CRT) was performed in 18 patients at least 3 months post-SCAD.
  • Coronary flow reserve (CFR) and index of microcirculatory resistance (IMR) were measured in SCAD and non-SCAD arteries.
  • Coronary microvascular dysfunction was defined as CFR <2.5 or IMR >25.

Main Results:

  • Seventy-one percent (12/17) of patients exhibited a CFR <2.5, indicating CMD.
  • Seventy-six percent (13/17) had an abnormal IMR (>25), also suggesting CMD.
  • No significant difference in CMD prevalence was observed between SCAD and non-SCAD arteries.

Conclusions:

  • Over 70% of patients with chronic chest pain post-SCAD demonstrate coronary microvascular dysfunction via invasive CRT.
  • The presence of CMD in both SCAD and non-SCAD arteries suggests underlying systemic vasculopathies, such as fibromuscular dysplasia, as a potential cause.
  • These findings highlight CMD as a significant contributor to persistent chest pain after SCAD.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
161
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
179
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
122
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
163
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
136
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
276